Next Generation Sequencing (NGS) Market Worth USD 21.36 Billion by 2026

Posted April 7, 2020 by jennysmith

Next Generation Sequencing (NGS) Market size is projected to grow from USD 5.48 Billion in 2018 to USD 21.36 Billion by 2026, at a CAGR of 18.43% from 2019 to 2026.

“Global Next Generation Sequencing (NGS) Market, By END USER (Academic & Government Institutes and Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Agriculture & Animal Research, Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), Service Type (Targeted Resequencing & Custom Gene Panels, RNA-SEQ, De Novo Sequencing, Exome Sequencing, Whole-Genome Sequencing, Others), and Region- Global Market Size, Status and Forecast to 2026″, published by Verified Market Research.

The Global Next Generation Sequencing (NGS) Market size is projected to grow from USD 5.48 Billion in 2018 to USD 21.36 Billion by 2026, at a CAGR of 18.43% from 2019 to 2026. Declining prices of next generation sequencing is expected to support market growth during the forecast period. Since the completion of the Human Genome Project, the cost of the next generation sequencing technique has significantly decreased and with time, is continuing to decline. The declining cost of the next generation sequencing can largely be attributed to decreasing Cost per Megabase of DNA Sequence and Cost per Genome.

Get | Download Sample Report @ –

Browse in-depth TOC on “Next Generation Sequencing (NGS) Market”

32 – Tables
43 – Figures
79 – Pages

In terms of value, the Diagnostics segment is estimated to be the largest and fastest-growing type in the Next Generation Sequencing (NGS) market in 2019.

The rapid technological evolution and widespread use of next-generation sequencing (NGS) in clinical laboratories have enabled incredible progress in the genetic diagnostics of several inherited disorders. The NGS progress is leading to the rise of the discovery of many genes associated with human inherited disorders and the elucidation of the molecular basis of complex disease. Moreover, NGS is widely used in diagnostics as on NGS platforms it is possible to perform a parallel sequencing of different target regions.

The availability of a skilled workforce for sample preparation is leading to the growth in the market as there are increasing advancements in sample preparation procedures and kits to standardize and simplify steps. This is leading to the increased ability to carry out sample preparation and is thereby driving the next generation sequencing market forward.

Get More Information @ –

The North American region is expected to be leading the growth in the generation sequencing market. The next generation sequencing market in North America is expected to grow at a rapid pace owing to the competitive environment that companies within the region have created. The competitive landscape of the region is very dynamic with more than 20 companies participating in the market and new competitors entering the market every year. In addition, the movement of sequencing technology into clinical settings is emerging, which provides an opportunity for the market to grow in this region.

Key players

Surmodics, Inc., Royal DSM, Hydromer Inc., Covalon Technologies Ltd., AST Products, Inc., Abbott, and Precision Coating Company, Inc. are the key players operating in the Next Generation Sequencing (NGS) market. Acquisitions and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Next Generation Sequencing (NGS), Market.

Obtain Report Details @
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By vmr
Country United States
Categories Business
Tags next generation sequencing ngs market
Last Updated April 7, 2020